Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Possibly through their actions upon glia, peroxisome proliferator-activated receptor agonists (PPAR) have been shown to alter the abuse potential of addictive drugs in several preclinical models. The current study extends this research into the human laboratory as the first clinical study into the e...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pharmacol Biochem Behav
Glavni autori: Jones, Jermaine D., Comer, Sandra D., Metz, Verena E., Manubay, Jeanne M., Mogali, Shanthi, Ciccocioppo, Roberto, Martinez, Suky, Mumtaz, Mudassir, Bisaga, Adam
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959043/
https://ncbi.nlm.nih.gov/pubmed/29020601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2017.10.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items